MedTrace Logo

Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System

NCT01480440 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-04-28

No results posted yet for this study

Summary

The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.

Conditions

  • Osteoarthritis
  • Rheumatoid Arthritis
  • Post-traumatic Arthritis
  • Ununited Humeral Head Fracture
  • Irreducible 3-and 4-part Proximal Humeral Fractures
  • Avascular Necrosis
  • Gross Rotator Cuff Deficiency
  • Revision Total Shoulder Arthroplasty

Interventions

DEVICE

Trabecular Metal Reverse Shoulder System

Trabecular Metal Reverse Shoulder System used in primary or revision total shoulder arthroplasty

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01480440 on ClinicalTrials.gov